{
  "zip": "3000",
  "sector": "Healthcare",
  "longBusinessSummary": "Amplia Therapeutics Limited, a pharmaceutical company, focuses on advancing a pipeline of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its clinical development pipeline comprises two lead molecules, AMP945 and AMP886 that inhibits (FAK). The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.",
  "city": "Melbourne",
  "phone": "61 2 8003 3650",
  "state": "VIC",
  "country": "Australia",
  "companyOfficers": [],
  "website": "http://www.ampliatx.com",
  "maxAge": 1,
  "address1": "55 Collins Street",
  "fax": "61 2 9225 5050",
  "industry": "Biotechnology",
  "address2": "Level 29",
  "previousClose": 0.1885,
  "regularMarketOpen": 0.1885,
  "twoHundredDayAverage": 0.192,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.1885,
  "navPrice": null,
  "averageDailyVolume10Day": 8040,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.1885,
  "fiftyDayAverage": 0.192,
  "trailingAnnualDividendRate": null,
  "open": 0.1885,
  "averageVolume10days": 8040,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.390704,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.1885,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 144,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 21271472,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 8040,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.1885,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 144,
  "fiftyTwoWeekHigh": 0.194,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.18,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.1885,
  "exchange": "PNK",
  "shortName": "AMPLIA THERAPEUTICS LTD",
  "longName": "Amplia Therapeutics Limited",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "INNMF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_25021935",
  "uuid": "cd1e35ee-43dd-36b8-b44b-e80a0991f1dd",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": -2.06387,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 107719000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.174,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1585612800,
  "heldPercentInstitutions": 0.15962,
  "netIncomeToCommon": null,
  "trailingEps": -0.061,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 1.0833334,
  "heldPercentInsiders": 0.33578998,
  "nextFiscalYearEnd": 1648684800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 54234068,
  "enterpriseValue": 20252628,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.1885,
  "logo_url": "https://logo.clearbit.com/ampliatx.com"
}